title: RNA-targeted Therapeutics for ALS.
abstract: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease leading to cell death of predominantly motor neurons. Despite extensive research in this disease, finding a way to slow the progress of the disease has been challenging. RNA-targeted therapeutic approaches, including small interfering RNA and antisense oligonucleotides are being developed for genetic forms of ALS. ALS provides an unique opportunity for the use of RNA inhibition strategies given a well-defined animal model, extensive available information regarding the causative genes, and recent experience in phase 1 clinical trial.
authors.affiliation: Department of Neurology, Washington University, 660 S. Euclid, St. Louis, MO, 63110, USA.
authors.forename: Linga V
authors.initials: LV
authors.lastname: Reddy
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Miller
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000378:metabolism* / Q000628:therapy*; D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D012313:RNA / Q000235:genetics / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000627:therapeutic use
chemical_list: D034741:RNA, Small Interfering; D012313:RNA